header image

Haematology

These plasma derived products are produced to the highest standards, using the latest technology, in state-of-the-art manufacturing facilities to ensure the most advanced therapies are available to patients globally. 

octanate

wilate

octanine F

octanate®

High-purity human Factor VIII / von Willebrand Factor (VWF) concentrate for prophylaxis and treatment of bleeding in patients with haemophilia A. Octanate undergoes two independent virus-inactivation steps (solvent/detergent treatment and terminal dry heat for 30 minutes at 100°C).

 

Available in vials of:

  • 250 IU
  • 500 IU
  • 1000 IU

 

You are now on Octapharma’s global website. Please select your country from the menu to access more detailed country-specific information or to contact your local Octapharma team.

wilate®

High-purity human von Willebrand Factor (VWF)/Factor VIII concentrate with the native VWF/FVIII complex in physiological 1:1 ratio and two independent virus inactivation steps (solvent/detergent treatment and terminal dry heat at 100°C for 120 min) for the treatment of patients with von Willebrand disease (VWD) and haemophilia A.

 

Available in vials of:

  • 500 IU
  • 1000 IU

 

You are now on Octapharma’s global website. Please select your country from the menu to access more detailed country-specific information or to contact your local Octapharma team.

octanine®F

High-purity human Factor IX concentrate with two independant virus inactivation and removal steps (solvent/detergent treatment and nanofiltration) for the prophylaxis and treatment of bleeding in patients with haemophilia B.


Available in vials of:

  • 250 IU
  • 500 IU
  • 1000 IU

 

You are now on Octapharma’s global website. Please select your country from the menu to access more detailed country-specific information or to contact your local Octapharma team.